Skip to main content
. 2022 Jun 1;66(6):e00237-22. doi: 10.1128/aac.00237-22

TABLE 2.

Collated PfIVT and counterscreen data for compounds from MMV’s Pandemic Box demonstrating >50% inhibition in a single-point IVT screen at 30 μMa

Compound PfIVT inhibition at 30 μM (%) IC50 value (μM)
PfIVT HsIVT Counterscreen
MMV688991 98.3 0.02 ± 0.007 0.04 ± 0.0003 0.04 ± 0.008
MMV002459 87.3 29 ± 0.9 (>30) 22 ± 0.3 >30
MMV1578897 93.4 0.04 ± 0.008 0.18 ± 0.001 0.4 ± 0.08
MMV1582495 89.9 0.6 ± 0.07 3.1 ± 0.04 1.7 ± 0.08
MMV1578578 74.6 3.7 ± 0.07 10 ± 0.12 1.3 ± 0.08
MMV1579781 72.4 8.1 ± 0.09 >30 0.5 ± 0.08
MMV1580839 73.3 0.8 ± 0.08 7.6 ± 0.12 8.3 ± 0.08
MMV124656 72.6 14 ± 0.9 17 ± 0.16 3.8 ± 0.08
MMV108465 62.6 17 ± 0.8 23 ± 0.11 7.6 ± 0.5
MMV247764 63.2 14 ± 0.7 23 ± 0.2 3.2 ± 0.06
MMV141011 51.8 >30 >30 10 ± 0.8
MMV003291 52.9 2 ± 0.07 >30 0.5 ± 0.08
MMV1634391 52.4 17 ± 0.6 1.1 ± 0.01 >30
a

All IC50 values represent the weighted mean ± standard deviation of two technical replicates. Compounds with IC50 values 1 order of magnitude (10-fold) higher for the counterscreen compared to the PfIVT assay are considered viable hits and are shaded.